BCG can trigger mechanisms that mimic HMGB1 effect: by inducing caspase-independent cell death in tumor cells, together with release of HMGB1 (67), and also by displaying ligands that predominantly bind to human TLR2 and TLR4 (49). This evidence concerns the gene HMGB1 and neoplasm.